A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certolizumab pegol administered concomitantly with DMARDs in subjects with active rheumatoid arthritis who participated in the study C87076. A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certol ...
A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certolizumab pegol administered concomitantly with DMARDs in subjects with active rheumatoid arthritis who participated in the study C87076. A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certol ...
Product Name: Certolizumab pegol Product Code: CDP870 INN or Proposed INN: Certolizumab pegol Other descriptive name: Anti-TNF humanized antibody Fab fragment - PEG conjugateProduct Name: Certolizumab pegol Product Code: CDP870 INN or Proposed INN: Certolizumab pegol Other des ...
A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certolizumab pegol administered concomitantly with DMARDs in subjects with active rheumatoid arthritis who participated in the study C87076. A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certol ...
A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certolizumab pegol administered concomitantly with DMARDs in subjects with active rheumatoid arthritis who participated in the study C87076. A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certol ...
Product Name: Certolizumab pegol Product Code: CDP870 INN or Proposed INN: Certolizumab pegol Other descriptive name: Anti-TNF humanized antibody Fab fragment - PEG conjugateProduct Name: Certolizumab pegol Product Code: CDP870 INN or Proposed INN: Certolizumab pegol Other des ...
A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certolizumab pegol administered concomitantly with DMARDs in subjects with active rheumatoid arthritis who participated in the study C87076. A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certol ...
A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certolizumab pegol administered concomitantly with DMARDs in subjects with active rheumatoid arthritis who participated in the study C87076. A Phase IIIB, multi-centre open label, follow-up study to evaluate the safety and efficacy of certol ...
Product Name: Certolizumab pegol Product Code: CDP870 INN or Proposed INN: Certolizumab pegol Other descriptive name: Anti-TNF humanized antibody Fab fragment - PEG conjugateProduct Name: Certolizumab pegol Product Code: CDP870 INN or Proposed INN: Certolizumab pegol Other des ...